title: Venous thromboembolism in patients with heart failure: in-hospital and chronic use of anti-coagulants for prevention.
abstract: Heart failure (HF) is a common clinical syndrome characterized by high morbidity and frequent hospitalizations. HF is an independent and major risk factor for venous thromboembolism (VTE) and VTE occurring in patients with HF carries a worse prognosis. The present review will focus on short and long term role of anti-coagulants in prevention of venous thrombosis in HF patients. We will also be discussing the recently investigated and patented anti-coagulants which could have a role in this specific population.
authors.affiliation: Dept of Cardiovascular Medicine, Lehigh Valley Hospital and Health Network, Allentown, Pennsylvania 18103, USA. nasirshariff@gmail.com
authors.forename: Nasir
authors.initials: N
authors.lastname: Shariff
authors.forename: Abdul
authors.initials: A
authors.lastname: Aleem
authors.forename: Vadim
authors.initials: V
authors.lastname: Levin
authors.forename: Ravi V
authors.initials: RV
authors.lastname: Desai
authors.forename: Sudip
authors.initials: S
authors.lastname: Nanda
authors.forename: Matthew W
authors.initials: MW
authors.lastname: Martinez
authors.forename: Stacey J
authors.initials: SJ
authors.lastname: Smith
authors.forename: Ronald
authors.initials: R
authors.lastname: Freudenberger
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D006333:Heart Failure / Q000097:blood / Q000150:complications*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000097:blood / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants